Edwards Lifesciences Corp. Share Price Today: Live Updates & Key Insights

Edwards Lifesciences Corp. share price today is $82.5, up 0.05%. The stock opened at $82.68 against the previous close of $82.46, with an intraday high of $82.925 and low of $81.875.

Edwards Lifesciences Corp. Share Price Chart

Edwards Lifesciences Corp.

us-stock
To Invest in {{usstockname}}
us-stock

Edwards Lifesciences Corp. Share Price Performance

$82.5 0.0005(0.05%) EW at 23 Mar 2026 12:57 PM Medical Devices
Lowest Today 81.875
Highest Today 82.925
Today’s Open 82.68
Prev. Close 82.46
52 Week High 87.89
52 Week Low 65.94
Day’s Range: Low 81.875 High 82.925
52-Week Range: Low 65.94 High 87.89
1 day return -
1 Week return -1.22
1 month return +0.06
3 month return -4.63
6 month return +11.9
1 year return +15.63
3 year return +3.92
5 year return +3.59
10 year return -

Edwards Lifesciences Corp. Institutional Holdings

Vanguard Total Stock Mkt Idx Inv 3.15

Vanguard Health Care Inv 2.58

Vanguard 500 Index Investor 2.55

Vanguard Mid Cap Index Institutional 2.16

iShares Core S&P 500 ETF 1.27

Fidelity 500 Index 1.27

State Street® SPDR® S&P 500® ETF 1.18

Vanguard Value Index Inv 0.92

Vanguard Mid-Cap Growth ETF 0.84

State Street®HlthCrSelSectSPDR®ETF 0.74

JPMorgan US Equity L 0.64

Vanguard Institutional Index I 0.57

Harbor Capital Appreciation Instl 0.57

BGF World Healthscience A2 0.54

State St S&P 500® Indx SL Cl III 0.53

Ninety One Global Franchise 0.51

Ninety One GSF Glb Frchs I Acc USD 0.51

UniGlobal 0.49

Vanguard Institutional 500 Index Trust 0.45

Fidelity Select Medical Tech and Devcs 0.42

HSBC Holdings PLC 0.38

Edwards Lifesciences Corp. Market Status

Strong Buy: 10

Buy: 4

Hold: 17

Sell: 0

Strong Sell: 1

Edwards Lifesciences Corp. Fundamentals

Market Cap 47916.00 M

PB Ratio 4.6329

PE Ratio 45.5801

Enterprise Value 44371.87 M

Total Assets 13697.20 M

Volume 4358664

Edwards Lifesciences Corp. Company Financials

Annual Revenue FY25:6067600000 6067.6M, FY23:5819000000 5819.0M, FY22:5382400000 5382.4M, FY21:5232500000 5232.5M, FY20:4386300000 4386.3M

Annual Profit FY25:4740700000 4740.7M, FY23:4538200000 4538.2M, FY22:4302000000 4302.0M, FY21:3983600000 3983.6M, FY20:3305700000 3305.7M

Annual Net worth FY25:1073500000 1073.5M, FY23:1430900000 1430.9M, FY22:1521900000 1521.9M, FY21:1503100000 1503.1M, FY20:823400000 823.4M

Quarterly Revenue Q4/2025:1569600000 1569.6M, Q3/2025:1553100000 1553.1M, Q2/2025:1532200000 1532.2M, Q1/2025:1412700000 1412.7M, Q3/2024:1354400000 1354.4M

Quarterly Profit Q4/2025:1229000000 1229.0M, Q3/2025:1209600000 1209.6M, Q2/2025:1189600000 1189.6M, Q1/2025:1111100000 1111.1M, Q3/2024:1091500000 1091.5M

Quarterly Net worth Q4/2025:91200000 91.2M, Q3/2025:291100000 291.1M, Q2/2025:329800000 329.8M, Q1/2025:358000000 358.0M, Q3/2024:3070800000 3070.8M

About Edwards Lifesciences Corp. & investment objective

Company Information Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL and EVOQUE brands. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS brand name; INSPIRIS RESILIA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valve conduit for complex combined procedures; and MITRIS RESILIA valve. It distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

Organisation Medical Devices

Employees 16000

Industry Medical Devices

CEO Mr. Bernard J. Zovighian

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Edwards Lifesciences Corp. FAQs

What is the share price of Edwards Lifesciences Corp. today?

The current share price of Edwards Lifesciences Corp. is $82.5.

Can I buy Edwards Lifesciences Corp. shares in India?

Yes, Indian investors can buy Edwards Lifesciences Corp. shares by opening an international trading and demat account with Motilal Oswal.

How to buy Edwards Lifesciences Corp. shares in India?

You can easily invest in Edwards Lifesciences Corp. shares from India by:

Can I buy fractional shares of Edwards Lifesciences Corp.?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Edwards Lifesciences Corp.?

Edwards Lifesciences Corp. has a market cap of $47916.00 M.

In which sector does Edwards Lifesciences Corp. belong?

Edwards Lifesciences Corp. operates in the Medical Devices sector.

What documents are required to invest in Edwards Lifesciences Corp. stocks?

To invest, you typically need:

What is the PE and PB ratio of Edwards Lifesciences Corp.?

The PE ratio of Edwards Lifesciences Corp. is 45.58 and the PB ratio is 4.63.